Digestive Disease Interventions
DOI: 10.1055/s-0044-1782147
Review Article

Pathophysiology, Diagnosis, and Management of Portal Hypertension in the Pediatric Population

1   Pediatric Gastroenterology Hepatology Nutrition, Cleveland Clinic Children's Hospital, Cleveland, Ohio
,
Sobia Laique
2   Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio
,
Kadakkal Radhakrishnan
1   Pediatric Gastroenterology Hepatology Nutrition, Cleveland Clinic Children's Hospital, Cleveland, Ohio
,
Sameer Gadani
3   Diagnostic Radiology, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations

Abstract

Portal hypertension is caused by resistance to the portal blood flow, which most commonly occurs in the setting of cirrhosis. Complications of portal hypertension can cause significant morbidity and mortality in the pediatric population. Portal hypertension is diagnosed when the hepatic venous pressure gradient (HVPG) is more than 5 mm Hg, and potential bleeding complications from esophageal and gastric varices are more likely when the HVPG is more than 10 mm Hg. Diagnosis can be made clinically; however, liver biopsy with measurement of the HVPG is ultimately required. The management of portal hypertension in pediatric patients is typically aimed at treatment of the complications. Despite the multiple pharmacologic, endoscopic, surgical, and interventional radiologic management techniques that are available, some pediatric patients will ultimately require liver transplant. Prompt referral is needed in such cases.



Publication History

Received: 17 January 2024

Accepted: 02 February 2024

Article published online:
06 March 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Gugig R, Rosenthal P. Management of portal hypertension in children. World J Gastroenterol 2012; 18 (11) 1176-1184
  • 2 Nakhleh RE. The pathological differential diagnosis of portal hypertension. Clin Liver Dis (Hoboken) 2017; 10 (03) 57-62
  • 3 Ponziani FR, Zocco MA, Campanale C. et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010; 16 (02) 143-155
  • 4 Ling SC. Portal hypertension in children. Clin Liver Dis (Hoboken) 2012; 1 (05) 139-142
  • 5 Etzion O, Koh C, Heller T. Noncirrhotic portal hypertension: an overview. Clin Liver Dis (Hoboken) 2015; 6 (03) 72-74
  • 6 Semela D. Systemic disease associated with noncirrhotic portal hypertension. Clin Liver Dis (Hoboken) 2015; 6 (04) 103-106
  • 7 Mangaonkar AA, Patnaik MM. Short telomere syndromes in clinical practice: bridging bench and bedside. Mayo Clin Proc 2018; 93 (07) 904-916
  • 8 Kaplan DE, Bosch J, Ripoll C. et al. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2023; DOI: 10.1097/HEP.0000000000000647.
  • 9 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (01) 217-231
  • 10 Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995; 108 (06) 1835-1841
  • 11 Bansal K, Gore M, Mittal S. Hepatopulmonary syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023
  • 12 Liu PMF, de Carvalho ST, Fradico PF, Cazumbá MLB, Campos RGB, Simões E Silva AC. Hepatorenal syndrome in children: a review. Pediatr Nephrol 2021; 36 (08) 2203-2215
  • 13 Woolfson JP, Perez M, Chavhan GB. et al. Sarcopenia in children with end-stage liver disease on the transplant waiting list. Liver Transpl 2021; 27 (05) 641-651
  • 14 Banc-Husu AM, Shiau H, Dike P, Shneider BL. Beyond varices: complications of cirrhotic portal hypertension in pediatrics. Semin Liver Dis 2023; 43 (01) 100-116
  • 15 Mews C, Sinatra F. Chronic liver disease in children. Pediatr Rev 1993; 14 (11) 436-444
  • 16 Kennedy P, Wagner M, Castéra L. et al. Quantitative elastography methods in liver disease: current evidence and future directions. Radiology 2018; 286 (03) 738-763
  • 17 Trout AT, Dillman JR, Xanthakos S. et al. Prospective assessment of correlation between US acoustic radiation force impulse and MR elastography in a pediatric population: dispersion of US shear-wave speed measurement matters. Radiology 2016; 281 (02) 544-552
  • 18 Hwang JY, Yoon HM, Kim JR. et al. Diagnostic performance of transient elastography for liver fibrosis in children: a systematic review and meta-analysis. AJR Am J Roentgenol 2018; 211 (05) W257-W266
  • 19 Pan Z, Li Z, Meng F, Hu Y, Zhang X, Chen Y. Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B. Diagn Interv Radiol 2022; 28 (01) 5-11
  • 20 Xanthakos SA, Podberesky DJ, Serai SD. et al. Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. J Pediatr 2014; 164 (01) 186-188
  • 21 Singh S, Venkatesh SK, Wang Z. et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015; 13 (03) 440-451.e6
  • 22 Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?. J Hepatol 2009; 50 (01) 17-35
  • 23 Horowitz JM, Venkatesh SK, Ehman RL. et al. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 2017; 42 (08) 2037-2053
  • 24 Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol 2015; 7 (17) 2069-2079
  • 25 Taouli B, Tolia AJ, Losada M. et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007; 189 (04) 799-806
  • 26 Natali GL, Cassanelli G, Paolantonio G, Parapatt GK, Gregori LM, Rollo M. Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt. Pediatr Radiol 2023; 53 (04) 727-738
  • 27 Dezsőfi A, Baumann U, Dhawan A. et al; ESPGHAN Hepatology Committee. Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2015; 60 (03) 408-420
  • 28 Amaral JG, Schwartz J, Chait P. et al. Sonographically guided percutaneous liver biopsy in infants: a retrospective review. AJR Am J Roentgenol 2006; 187 (06) W644-W649
  • 29 Short SS, Papillon S, Hunter CJ. et al. Percutaneous liver biopsy: pathologic diagnosis and complications in children. J Pediatr Gastroenterol Nutr 2013; 57 (05) 644-648
  • 30 Westheim BH, Østensen AB, Aagenæs I, Sanengen T, Almaas R. Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr 2012; 55 (01) 82-87
  • 31 Matos H, Noruegas MJ, Gonçalves I, Sanches C. Effectiveness and safety of ultrasound-guided percutaneous liver biopsy in children. Pediatr Radiol 2012; 42 (11) 1322-1325
  • 32 Govender P, Jonas MM, Alomari AI. et al. Sonography-guided percutaneous liver biopsies in children. AJR Am J Roentgenol 2013; 201 (03) 645-650
  • 33 Pietrobattista A, Fruwirth R, Natali G, Monti L, Devito R, Nobili V. Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension. Pediatr Radiol 2009; 39 (09) 959-961
  • 34 Mandal S, Miraglia R, Maruzzelli L. et al. US-guided percutaneous liver biopsy in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 2014; 58 (06) 756-761
  • 35 Dohan A, Guerrache Y, Boudiaf M, Gavini J-P, Kaci R, Soyer P. Transjugular liver biopsy: indications, technique and results. Diagn Interv Imaging 2014; 95 (01) 11-15
  • 36 Colecchia A, Ravaioli F, Marasco G. et al. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol 2018; 69 (02) 308-317
  • 37 Miraglia R, Luca A, Maruzzelli L. et al. Measurement of hepatic vein pressure gradient in children with chronic liver diseases. J Hepatol 2010; 53 (04) 624-629
  • 38 Ebel NH, Carlin K, Shaffer ML. et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. J Pediatr Gastroenterol Nutr 2019; 68 (06) 788-792
  • 39 Sousa M, Fernandes S, Proença L. et al. The Baveno VI criteria for predicting esophageal varices: validation in real life practice. Rev Esp Enferm Dig 2017; 109 (10) 704-707
  • 40 Grammatikopoulos T, McKiernan PJ, Dhawan A. Portal hypertension and its management in children. Arch Dis Child 2018; 103 (02) 186-191
  • 41 Monroe EJ, Shivaram GM. Pediatric hepatobiliary interventions in the setting of intrahepatic vascular malformations, portal hypertension, and liver transplant. Semin Roentgenol 2019; 54 (04) 311-323
  • 42 Sanín E, Suárez-Galvis M, Álvarez S, Santamaría A. Transjugular intrahepatic portosystemic shunt creation in children weighing <10 kg using an unconventional technique. J Vasc Interv Radiol 2023; 34 (06) 1070-1074
  • 43 Hermie L, Van Cauwenberghe L, Dhondt E, De Bruyne R, Defreyne L. Transjugular intrahepatic portosystemic shunts in pediatric portal hypertension: a systematic review and meta-analysis. J Vasc Interv Radiol 2023; 34 (08) 1382-1398.e10
  • 44 Liu A, Obi C, Thakor AS. Transjugular intrahepatic portosystemic shunt with portal vein recannulation (TIPS-PVR) in pediatric patients. Pediatr Transplant 2023; 27 (08) e14554
  • 45 Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 1997; 46 (01) 8-14
  • 46 Deswal S, Madhusudhan KS, Sharma S, Malik R. Balloon-occluded retrograde transvenous obliteration (BRTO): a treatment option in children with gastric varices. Indian J Pediatr 2020; 87 (12) 1078-1079
  • 47 Vittorio J, Orellana K, Martinez M. et al. Partial splenic embolization is a safe and effective alternative in the management of portal hypertension in children. J Pediatr Gastroenterol Nutr 2019; 68 (06) 793-798
  • 48 Talwar A, Gabr A, Riaz A. et al. Adverse events related to partial splenic embolization for the treatment of hypersplenism: a systematic review. J Vasc Interv Radiol 2020; 31 (07) 1118-1131.e6
  • 49 Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertension. Semin Intervent Radiol 2012; 29 (02) 135-139
  • 50 N'Kontchou G, Seror O, Bourcier V. et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 2005; 17 (02) 179-184
  • 51 Young V, Rajeswaran S. Management of portal hypertension in the pediatric population: a primer for the interventional radiologist. Semin Intervent Radiol 2018; 35 (03) 160-164
  • 52 Squires RH, Ng V, Romero R. et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology 2014; 60 (01) 362-398